Telemedicine-based adapted physical activity programs for pediatric oncology patients in active oncological care: a feasibility study [0.03%]
基于远程医疗的儿科肿瘤学患者的适应性身体活动计划：一项可行性研究
Linda Peli,Elisa Inselvini,Marta Cogliati et al.
Linda Peli et al.
Background: Survival rates for pediatric hematological malignancies have significantly improved over the last 50 years. However, children undergoing cancer treatment face long- term health challenges, including musculoske...
First evidence of Retzius-sparing robot-assisted radical prostatectomy with the Versius robotic surgical system [0.03%]
Versius机器人手术系统的Retzian保留的机器人辅助根治性前列腺切除术的第一例证据
Erika Palagonia,Stefano Tappero,Elio Mazzone et al.
Erika Palagonia et al.
We describe the first experience of Retzius-sparing robot-assisted radical prostatectomy (RS-RARP) performed with the Versius robotic system (CMR Surgical, Cambridge, UK). Five patients underwent RS-RARP at ASST Grande Ospedale Metropolitan...
Evaluation of a PSA and transrectal prostate ultrasound video-based machine learning model as a tool for prostate cancer diagnosis [0.03%]
基于PSA和经直肠前列腺超声视频的机器学习模型在前列腺癌诊断中的评估研究
Yanhong Du,Anli Zhao,Maoliang Zhang et al.
Yanhong Du et al.
Objective: To develop a machine learning-based model incorporating prostate-specific antigen (PSA) levels and prostate ultrasound video clips for diagnosing prostate cancer. ...
Case report series: Pembrolizumab and enfortumab vedotin in plasmacytoid urothelial carcinoma [0.03%]
病例报告系列：帕博利珠单抗和恩沃鲁单抗治疗浆细胞样尿路上皮癌
Susanna G Bowen,Derek B Allison,Patrick J Hensley et al.
Susanna G Bowen et al.
Plasmacytoid urothelial carcinoma (PUC) is a rare and aggressive histologic subtype of urothelial carcinoma with no well-established treatment. Recently, the combination of pembrolizumab and enfortumab vedotin has become the standard of car...
Blood memory CD8 T cell phenotypes in lung cancer patients predict immune checkpoint treatment responses [0.03%]
肺癌患者的血液记忆CD8 T细胞表型预测免疫检查点治疗反应
Florian Schmidt,Kan Xing Wu,Yovita Ida Purwanti et al.
Florian Schmidt et al.
Background: Immune checkpoint inhibition (ICI) has become a standard treatment to re-invigorate tumor-attacking T cell responses in multiple cancer indications, yet a patient's response is unpredictable even with a confir...
Mathematical modeling of the effect of early detection in breast cancer treatment [0.03%]
乳腺癌治疗早期检测效果的数学模型研究
Farouk Tijjani Saad,Yusuf Ya&#x;u Gambo,Phollakrit Wongsantisuk et al.
Farouk Tijjani Saad et al.
Introduction: Early detection is a cornerstone of cancer control, yet its quantitative influence on tumor-immune interactions remains underexplored in mathematical oncology. ...
Immunotherapy rechallenge after ICI-related pneumonitis in lung cancer patients: a retrospective cohort study [0.03%]
免疫检查点抑制剂相关肺炎的肺癌患者接受免疫治疗再挑战：一项回顾性队列研究
Guixian Wu,Jingjing Qu,Jing Zheng et al.
Guixian Wu et al.
Background: Immune checkpoint inhibitors (ICIs) have significant advantages in treating lung cancer due to their low toxicity and high efficacy. However, adverse events, especially ICI-related pneumonitis (CIP), may restr...
Case Report: Synchronous cervical, gastric and rectal metastases in occult breast cancer [0.03%]
隐匿性乳腺癌伴颈部、胃和直肠转移的病例报告
Ruoying Deng,Ze Meng,Qiang Li et al.
Ruoying Deng et al.
Occult breast cancer (OBC) is characterized as a breast carcinoma that remains undetectable through imaging modalities. OBC is a rare condition, accounting for only 0.3%-1.0% of all breast cancers, and is often clinically associated with me...
Identification of MAEA protein as a potential target for chemoresistance in osteosarcoma using bioinformatics and proteomic analysis [0.03%]
基于生物信息学和蛋白质组分析的软骨肉瘤耐药潜在治疗靶点MAEA蛋白识别研究
Chen Zhang,Ruizhen Wang,Xin Yi et al.
Chen Zhang et al.
Introduction: Osteosarcoma (OS) is the most common bone tumor, characterized by a high incidence, rapid progression, and frequent metastases. The implementation of chemotherapy has made important progress, while the necro...
Correction: T-cell depleted haploidentical transplantation in children with hematological malignancies: a comparison between CD3+/CD19+ and TCRαβ+/CD19+ depletion platforms [0.03%]
儿童恶性血液病半相合移植T细胞去除方案比较-CD3+/CD19+与TCRαβ+/CD19+平台的对比研究校正稿
Marta Gonzalez-Vicent,Blanca Molina,Ivan Lopez et al.
Marta Gonzalez-Vicent et al.
[This corrects the article DOI: 10.3389/fonc.2022.884397.]. Keywords: T-cell depletion; children; haploident...
Published Erratum
Frontiers in oncology. 2025 Sep 8:15:1680867. DOI:10.3389/fonc.2025.1680867 2025